CollPlant Biotechnologies (CLGN) Revenue (2017 - 2026)
CollPlant Biotechnologies' (CLGN) quarterly Revenue came in at $73000.0 in Q1 2026, down 96.45% YoY from $2.1 million in Q1 2025, and up 21.67% on a QoQ basis from $60000.0 in Q4 2025.
CollPlant Biotechnologies (CLGN) Revenue (2017 - 2026) Analysis & Trends
CollPlant Biotechnologies (CLGN) has 10 years of Revenue data on file, last reported at $73000.0 in Q1 2026.
- Quarterly Revenue fell 96.45% year-over-year to $73000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $389000.0 (down 84.26% YoY) and the FY2025 annual result came in at $2.4 million, up 360.39% from the prior year.
- Revenue advanced to $73000.0 in Q1 2026, from $60000.0 in the prior quarter.
- In the past five years, Revenue ranged from a high of $43.0 billion in Q3 2023 to a low of $4000.0 in Q3 2024.
- A 5-year average of $2.7 billion and a median of $136500.0 in 2022 frame the typical range for Revenue.
- Annual changes were most pronounced in 2023 — Revenue soared 39449441.28% — and 2024, when it sank 100.0%.
- Tracing CLGN's Revenue over 5 years: stood at $58000.0 in 2022, then jumped by 415.52% to $299000.0 in 2023, then sank by 45.15% to $164000.0 in 2024, then slumped by 63.41% to $60000.0 in 2025, then climbed by 21.67% to $73000.0 in 2026.
- The last three Revenue figures came in at $73000.0 (Q1 2026), $60000.0 (Q4 2025), and $77000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.05 Bn | 131.20 Bn | 2.84 Bn | 3.33 Bn |
| 2 | Regeneron Pharmaceuticals | 85.99 Bn | 78.00 Bn | 3.93 Bn | 4.29 Bn |
| 3 | Argenx Se | 65.49 Bn | 60.31 Bn | 1.37 Bn | 1.52 Bn |
| 4 | Moderna | 56.79 Bn | 51.65 Bn | 52.00 Mn | 145.00 Mn |
| 5 | BeOne Medicines | 42.14 Bn | 37.05 Bn | 1.53 Bn | 1.71 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.27 Bn | 992.69 Mn | 1.29 Bn |
| 7 | BioNTech SE | 27.71 Bn | 9.32 Bn | 668.28 Mn | 1.06 Bn |
| 8 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 425.49 Mn |
| 9 | Royalty Pharma | 27.35 Bn | 26.51 Bn | - | 674.14 Mn |
| 10 | CollPlant Biotechnologies | 4.23 Mn | 4.23 Mn | -243,000.00 | 73,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 30, 2026 | 73,000.00 |
| Dec 31, 2025 | 60,000.00 |
| Sep 30, 2025 | 77,000.00 |
| Jun 30, 2025 | 179,000.00 |
| Mar 30, 2025 | 2.06 Mn |
| Dec 31, 2024 | 164,000.00 |
| Sep 30, 2024 | 4,000.00 |
| Jun 30, 2024 | 249,000.00 |
| Mar 31, 2024 | 98,000.00 |
| Dec 31, 2023 | 299,000.00 |
| Sep 30, 2023 | 43.00 Bn |
| Jun 30, 2023 | 10.18 Mn |
| Mar 31, 2023 | 433,000.00 |
| Dec 31, 2022 | 58,000.00 |
| Sep 30, 2022 | 109,000.00 |
| Jun 30, 2022 | 66,000.00 |
| Dec 31, 2021 | 310,000.00 |
| Sep 30, 2021 | 140,000.00 |
| Jun 30, 2021 | 691,000.00 |
| Mar 31, 2021 | 14.50 Mn |